BRIEF-Fennec qtrly loss per share $0.04

Thu May 12, 2016 6:17am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 12 (Reuters) - Fennec Pharmaceuticals Inc :

* Qtrly loss per share $0.04

* Entered into agreement with elion oncology involving transfer by fennec of intellectual property, data relating to eniluracil

* Agreement for transfer by co of intellectual property relating to eniluracil,adh-1 technologies,development programs to elion

* Fennec provides corporate update and announces first quarter 2016 results Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)